EN
HI
Summary
As of 9 Sep, 2026, Dr Lal Pathlabs. stock price is ₹1912.5. During the trading session, the stock has moved between an intraday low of ₹1881.40 and an intraday high of ₹1920.00. Over the last 52 weeks, Dr Lal Pathlabs. has traded between ₹1272.60 and ₹1988.90.
The stock has recorded a trading volume of 90,505 shares, with a market capitalization of ₹167637770. Its Average Traded Price (ATP) is ₹1905.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 8 @ ₹1912.50.
Dr Lal Pathlabs. has an upper circuit limit of ₹2282.20 and a lower circuit limit of ₹1521.60. The total value traded stands at ₹17.24 CR, and the delivery percentage for the day is 39.53%.
The stock is currently traded with a market lot size of 1. Dr Lal Pathlabs. also offers a dividend yield of 1.08%.
Dr Lal Pathlabs share price chart
Dr Lal Pathlabs. Share Key Metrics
Volume
90505.00
Market Cap
32060.72 CR
LTQ@LTP
8@1912.50
ATP
1905
Var Margin
15.07 %
Circuit Range
1521.6-2282.2
Delivery %
39.53 %
Value
17.24 CR
ASM/GSM
No
Market Lot
1
Dr Lal Pathlabs. Fundamentals
P/E Ratio
58.9
P/B Ratio
12.22
Div. Yield
1.08
Sector P/E
56.36
Sector P/B
-13.8
Sec. Div. Yield
0.16
Dr Lal Pathlabs. Resistance and Support
Pivot 1895
Resistance
First Resistance
1919.9
Second Resistance
1937.9
Third Resistance
1962.8
Support
First Support
1877
Second Support
1852.1
Third Support
1834.1
Dr Lal Pathlabs. Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 08 2026 | 1881.4 | 1912.5 | 0.56% | 1920 | 1881.4 |
| Mon Sep 07 2026 | 1880 | 1901.9 | 1.30% | 1913 | 1870.09 |
| Fri Sep 04 2026 | 1920.5 | 1877.5 | -2.48% | 1925.19 | 1855.69 |
Dr Lal Pathlabs. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-24 | Quarterly Results |
| 2026-04-30 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results & Interim Dividend |
| 2025-10-31 | Qtr Results |
| 2025-07-31 | Quarterly Results |
| 2025-04-25 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-23 | Quarterly Results & Interim Dividend |
| 2024-08-07 | Quarterly Results & Interim Dividend |
Dr Lal Pathlabs. News
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Dr. Lal Path Labs' wholly-owned subsidiary, Dr. Lal Ventures Private Limited, has completed the acquisition of a 30% stake in Neuome Technologies Private Limited. The transaction, previously approved by the Board, makes Neuome an associate company, potentially enhancing the group's technological footprint.
Aug 27 2026 19:11:35
Dr. Lal PathLabs Ltd - 539524 - Incorporation Of A Step-Down Subsidiary Company
Dr. Lal Path Labs' wholly owned subsidiary, Dr Lal PathLabs FZCO, Dubai, incorporated a new step-down subsidiary named 'Dr Lal PathLabs Indomed LLC' in Tashkent, Uzbekistan. This entity will hold 70% of its share capital and will provide diagnostic services, strengthening the group's presence in the region.
Aug 19 2026 18:24:04
Dr Lal Pathlabs. Management
| Name | Position |
|---|---|
| Vinay Gujral | Company Secretary & Compliance Officer |
| Arvind Lal | Chairman |
Dr Lal Pathlabs. Similar Stocks
Narayana Hrudayalaya Ltd.
1897.40
-14.40 (0.75%)
Emcure Pharmaceuticals Ltd.
1925.80
-1.00 (0.05%)
Wockhardt Ltd.
2224.00
16.00 (0.72%)
Sai Life Sciences Ltd.
1647.10
67.50 (4.27%)
Krishna Institute of Medical Sciences Ltd
764.50
-0.05 (0.01%)
Rubicon Research Ltd.
1860.60
112.20 (6.42%)
Neuland Laboratories Ltd.
23995.00
1125.00 (4.92%)
Piramal Pharma Ltd.
226.62
6.96 (3.17%)
Acutaas Chemicals Ltd.
3182.10
0.50 (0.02%)
Dr Lal Pathlabs. FAQs
The Buying Price of Dr Lal Pathlabs. share is 1912.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Dr Lal Pathlabs. stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Dr Lal Pathlabs., choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Dr Lal Pathlabs. shares is 58.9. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Dr Lal Pathlabs. shares is 12.22. Useful to assess the stock's value relative to its book value.
To assess Dr Lal Pathlabs.’s valuation compare Sector P/E, P/B which are 56.36 & -13.8 with sector averages, along with growth rates and financial metrics.
The Market Cap of Dr Lal Pathlabs. is 32060.72 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Dr Lal Pathlabs. share price is 1988.90 & 1272.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Dr Lal Pathlabs. belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in LALPATHLAB
Or Download Choice FinX App
Invest in LALPATHLAB
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade